scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JACI.2005.10.045 |
P698 | PubMed publication ID | 16461161 |
P50 | author | Teresa Caballero | Q52822293 |
P2093 | author name string | Concepción López-Serrano | |
P433 | issue | 2 | |
P921 | main subject | hereditary angioedema | Q2096745 |
anaphylaxis | Q168800 | ||
P304 | page(s) | 476-7; discussion 477 | |
P577 | publication date | 2006-02-01 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema | |
P478 | volume | 117 |
Q36839961 | C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies? |
Q37354117 | Current and emerging management options for hereditary angioedema in the US. |
Q38021414 | Current management options for hereditary angioedema |
Q36373700 | Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project |
Q34575895 | Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant |
Q34067727 | HAE international home therapy consensus document. |
Q34063768 | HAE therapies: past present and future |
Q34741437 | Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies |
Q36998879 | Human plasma kallikrein-kinin system: physiological and biochemical parameters |
Q34139106 | Management of acute attacks of hereditary angioedema: potential role of icatibant |
Q35623619 | Safety and efficacy of physician-supervised self-managed C1 inhibitor replacement therapy. |